Baidu
map
ADV DRUG DELIVER REV 润色咨询

ADVANCED DRUG DELIVERY REVIEWS

出版年份：1987 年文章数：2871 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5% <br> sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    各个杂志社对关键词的数目有要求么？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5% <br> sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]
    2021-12-27 Mia

    一般期刊要求关键词有多少个？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5% <br> sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]
    2019-02-28 ms9497043704145630

    很方便啊，以后会常来的。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5% <br> sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]
    2018-10-27 nnnuclear

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5% <br> sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]
    2016-07-07 ms3036779279854874

    研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5%
    sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1086164, encodeId=760d1086164c0, content=各个杂志社对关键词的数目有要求么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086163, encodeId=7d251086163b0, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849949, encodeId=086a84994921, content=很方便啊，以后会常来的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Thu Feb 28 09:36:39 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562424, encodeId=333856242447, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：一般都是以Issue的形式发邀稿，每期Issue大概10篇左右的高质量综述，对相关领域的现状做论述并对未来的发展做展望。不发Stand alone的综述。一般都是领域内的大咖写个proposal，投到编辑部，编辑审核通过后，再由Issue editor所邀请的作者撰稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Sat Oct 27 00:00:00 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832618, encodeId=ce9f83261831, content=研究方向：生物工程 药学 医学 审稿时间:约3个月 接收率：约5% <br> sci(2014)：15.038 好杂志。发了很多生物工程方面的文章。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdbe5414035, createdName=ms3036779279854874, createdTime=Thu Jul 07 15:47:41 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523304, encodeId=8584523304f3, content=审稿速度:3.0 | 投稿命中率:5.0<br>经验分享：好杂志。发了很多生物工程方面的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f12108544, createdName=taddy, createdTime=Fri Jun 10 16:16:00 CST 2016, time=2016-06-10, status=1, ipAttribution=)]
    2016-06-10 taddy

    审稿速度:3.0 | 投稿命中率:5.0
    经验分享：好杂志。发了很多生物工程方面的文章。

    0

共8条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map